deltatrials
Active Not Recruiting OBSERVATIONAL NCT05140369

CLL Therapy Approaches in Russia (CLL registry)

Observational Retrospective-Prospective Study on CLL Therapy Approaches in Russia.

Sponsor: AstraZeneca

Conditions Chronic Lymphocytic Leukemia
Updated 38 times since 2022 Last updated: Jan 19, 2026 Started: Oct 29, 2021 Primary completion: Mar 31, 2027 Completion: Mar 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Lymphocytic Leukemia, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 38 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshot~Apr 2022 – ~Jun 2022 · 2 months · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Dec 2024 · 30 days · monthly snapshot~Dec 2024 – ~Jan 2025 · 31 days · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Aug 2025 · 3 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

38 versions recorded

  1. Feb 2026 — Present [monthly]

    Active Not Recruiting

  2. Sep 2025 — Feb 2026 [monthly]

    Active Not Recruiting

  3. Aug 2025 — Sep 2025 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  4. May 2025 — Aug 2025 [monthly]

    Recruiting

  5. Apr 2025 — May 2025 [monthly]

    Recruiting

▶ Show 33 earlier versions

  1. Mar 2025 — Apr 2025 [monthly]

    Recruiting

  2. Feb 2025 — Mar 2025 [monthly]

    Recruiting

  3. Jan 2025 — Feb 2025 [monthly]

    Recruiting

  4. Dec 2024 — Jan 2025 [monthly]

    Recruiting

  5. Nov 2024 — Dec 2024 [monthly]

    Recruiting

  6. Oct 2024 — Nov 2024 [monthly]

    Recruiting

  7. Sep 2024 — Oct 2024 [monthly]

    Recruiting

  8. Aug 2024 — Sep 2024 [monthly]

    Recruiting

  9. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  10. Jun 2024 — Jul 2024 [monthly]

    Recruiting

  11. May 2024 — Jun 2024 [monthly]

    Recruiting

  12. Apr 2024 — May 2024 [monthly]

    Recruiting

  13. Mar 2024 — Apr 2024 [monthly]

    Recruiting

  14. Feb 2024 — Mar 2024 [monthly]

    Recruiting

  15. Jan 2024 — Feb 2024 [monthly]

    Recruiting

  16. Dec 2023 — Jan 2024 [monthly]

    Recruiting

  17. Nov 2023 — Dec 2023 [monthly]

    Recruiting

  18. Oct 2023 — Nov 2023 [monthly]

    Recruiting

  19. Sep 2023 — Oct 2023 [monthly]

    Recruiting

  20. Aug 2023 — Sep 2023 [monthly]

    Recruiting

  21. Jul 2023 — Aug 2023 [monthly]

    Recruiting

  22. Jun 2023 — Jul 2023 [monthly]

    Recruiting

  23. Apr 2023 — Jun 2023 [monthly]

    Recruiting

  24. Feb 2023 — Apr 2023 [monthly]

    Recruiting

  25. Jan 2023 — Feb 2023 [monthly]

    Recruiting

  26. Dec 2022 — Jan 2023 [monthly]

    Recruiting

  27. Nov 2022 — Dec 2022 [monthly]

    Recruiting

  28. Sep 2022 — Nov 2022 [monthly]

    Recruiting

  29. Jul 2022 — Sep 2022 [monthly]

    Recruiting

  30. Jun 2022 — Jul 2022 [monthly]

    Recruiting

  31. Apr 2022 — Jun 2022 [monthly]

    Recruiting

  32. Feb 2022 — Apr 2022 [monthly]

    Recruiting

  33. Jan 2022 — Feb 2022 [monthly]

    Recruiting

    First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Belgorod, Russia , Bryansk, Russia , Chelyabinsk, Russia , Chita, Russia , Irkutsk, Russia , Kaliningrad, Russia , Kaluga, Russia , Kazan', Russia , Kirov, Russia , Krasnoyarsk, Russia and 24 more locations